Cell Source, Inc. (CLCS) SEC Filings & Financial Intelligence
Cell Source, Inc. (CLCS) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CLCS
CIK: 1569340
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerBruce Roff
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-05-14 | 2025-03-31 | 10-Q | 0001493152-26-022926 | View SEC Doc Filr Page |
| 10-K | 2026-04-07 | 2024-12-31 | 10-K | 0001493152-26-015359 | View SEC Doc Filr Page |
| 15-12G | 2025-07-16 | — | 15-12G | 0001641172-25-019898 | View SEC Doc Filr Page |
| 8-K | 2025-06-27 | 2025-06-26 | 8-K | 0001641172-25-016833 | View SEC Doc Filr Page |
| NT 10-K | 2025-03-28 | 2024-12-31 | NT 10-K Filing | 0001641172-25-001080 | View SEC Doc Filr Page |
| 10-Q | 2024-11-14 | 2024-09-30 | 10-Q Filing | 0001493152-24-045964 | View SEC Doc Filr Page |
| 10-Q | 2024-08-19 | 2024-06-30 | 10-Q Filing | 0001493152-24-033055 | View SEC Doc Filr Page |
| NT 10-Q | 2024-08-14 | 2024-06-30 | NT 10-Q Filing | 0001493152-24-032056 | View SEC Doc Filr Page |
| 10-Q | 2024-07-29 | 2024-03-31 | 10-Q Filing | 0001493152-24-029448 | View SEC Doc Filr Page |
| 10-K | 2024-06-24 | 2023-12-31 | 10-K Filing | 0001493152-24-024903 | View SEC Doc Filr Page |
| 8-K | 2024-04-09 | 2024-03-22 | 8-K Filing | 0001493152-24-014035 | View SEC Doc Filr Page |
| NT 10-K | 2024-04-01 | 2023-12-31 | NT 10-K Filing | 0001493152-24-012389 | View SEC Doc Filr Page |
| 10-Q | 2023-11-09 | 2023-09-30 | 10-Q Filing | 0001493152-23-040079 | View SEC Doc Filr Page |
| D | 2023-10-06 | — | D Filing | 0001493152-23-036455 | View SEC Doc Filr Page |
| 10-Q | 2023-09-19 | 2023-06-30 | 10-Q Filing | 0001493152-23-033011 | View SEC Doc Filr Page |
| 10-Q | 2023-08-23 | 2023-03-31 | 10-Q Filing | 0001493152-23-029915 | View SEC Doc Filr Page |
| NT 10-Q | 2023-08-15 | 2023-06-30 | NT 10-Q Filing | 0001493152-23-028930 | View SEC Doc Filr Page |
| 10-K | 2023-08-08 | 2022-12-31 | 10-K Filing | 0001493152-23-027069 | View SEC Doc Filr Page |
| NT 10-Q | 2023-05-16 | 2023-03-31 | NT 10-Q Filing | 0001493152-23-017688 | View SEC Doc Filr Page |
| NT 10-K | 2023-03-31 | 2022-12-31 | NT 10-K Filing | 0001493152-23-009987 | View SEC Doc Filr Page |
| 10-Q | 2022-12-08 | 2022-09-30 | 10-Q Filing | 0001493152-22-034876 | View SEC Doc Filr Page |
| 10-Q | 2022-12-02 | 2022-06-30 | 10-Q Filing | 0001493152-22-034255 | View SEC Doc Filr Page |
| 10-Q | 2022-11-02 | 2022-03-31 | 10-Q Filing | 0001493152-22-030233 | View SEC Doc Filr Page |
| 8-K | 2022-07-21 | 2022-07-18 | 8-K Filing | 0001493152-22-019997 | View SEC Doc Filr Page |
| NT 10-Q | 2022-05-12 | 2022-03-31 | NT 10-Q Filing | 0001493152-22-013010 | View SEC Doc Filr Page |